Clinical trial

A Study of SHR3680, HS-20093 and SHR2554 in Subjects With Prostate Cancer

NCT07230106

Drugs and interventions used in this trial

6 registered

These interventions are listed by ClinicalTrials.gov. An RxNorm link indicates a mapped medicine record; the registry name alone is not proof of a specific branded formulation.

Search this trial's interventions

DRUG · Unmapped registry intervention HS-20093 for Injection Find medicine records · Find other trials using this name

DRUG · Unmapped registry intervention SHR3680 Tablet Find medicine records · Find other trials using this name

DRUG · Unmapped registry intervention Abiraterone Tablet Find medicine records · Find other trials using this name

DRUG · Unmapped registry intervention SHR2554 Tablet Find medicine records · Find other trials using this name

DRUG · Unmapped registry intervention Enzalutamide Tablet Find medicine records · Find other trials using this name

DRUG · Unmapped registry intervention Darotamine Capsule Find medicine records · Find other trials using this name

Study at a glance

Registry-backed

A Study of SHR3680, HS-20093 and SHR2554 in Subjects With Prostate Cancer

Design: INTERVENTIONAL · Status: RECRUITING · Phase: PHASE2

Read study objectives, eligibility and outcome measures at ClinicalTrials.gov

StatusRECRUITING

Study typeINTERVENTIONAL

Start date2025-12-08

PhasePHASE2

Conditions

Prostate Cancerverified · MONDO: prostate cancer

Interventions

HS-20093 for InjectionDRUG

SHR3680 TabletDRUG

Abiraterone TabletDRUG

SHR2554 TabletDRUG

Enzalutamide TabletDRUG

Darotamine CapsuleDRUG

Sponsors & collaborators

Jiangsu HengRui Medicine Co., Ltd.lead sponsor

Mapped research locations

NanjingJiangsu, China1 TianjinTianjin Municipality, China1

Registry source

Open the source record to verify current eligibility, contacts, locations and registry updates.

Open NCT07230106 on ClinicalTrials.gov ↗

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.